This topic contains a solution. Click here to go to the answer

Author Question: In a laboratory setting, a rat has experienced shock each time it is placed inside Chamber A. Over ... (Read 14 times)

CORALGRILL2014

  • Hero Member
  • *****
  • Posts: 525
In a laboratory setting, a rat has experienced shock each time it is placed inside Chamber A. Over time, the rat shows a fear response as soon as it is placed in the chamber.
 
  After the destruction of the ______________ of the amygdala, the animal no longer shows a fear response when placed in the chamber.
 
  a. central nucleus
  b. lateral nucleus
  c. basal nucleus
  d. dorsal nucleus

Question 2

The amygdala is located in the ___________ lobe(s).
 
  a. occipital
  b. parietal
  c. temporal
  d. frontal



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tdewitt

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer: A

Answer to Question 2

Answer: C




CORALGRILL2014

  • Member
  • Posts: 525
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


amcvicar

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library